Literature DB >> 19158372

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.

Teresa Adragao1, Johann Herberth, Marie-Claude Monier-Faugere, Adam J Branscum, Anibal Ferreira, Joao M Frazao, Jose Dias Curto, Hartmut H Malluche.   

Abstract

BACKGROUND AND OBJECTIVES: There is increasing evidence that altered bone metabolism is associated with cardiovascular calcifications in patients with stage 5 chronic kidney disease on hemodialysis (HD). This study was conducted to evaluate the association between bone volume, turnover, and coronary calcifications in HD patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a cross-sectional study, bone biopsies and multislice computed tomography were performed in 38 HD patients. Bone volume/total volume, activation frequency, and bone formation rate/bone surface were determined by histomorphometry and coronary calcifications were quantified by Agatston scores.
RESULTS: Prevalence of low bone turnover was 50% and of low bone volume was 16%. Among the studied traditional cardiovascular risk factors, only age was found to be associated with coronary calcifications. Lower bone volume was a significant risk factor for coronary calcifications during early years of HD, whereas this effect was not observed in patients with dialysis duration >6 yr. Histomorphometric parameters of bone turnover were not associated with coronary calcifications.
CONCLUSIONS: Low bone volume is associated with increased coronary calcifications in patients on HD.

Entities:  

Mesh:

Year:  2009        PMID: 19158372      PMCID: PMC2637600          DOI: 10.2215/CJN.01870408

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  27 in total

1.  Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; G M London
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

Review 2.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

3.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.

Authors:  W G Goodman; J Goldin; B D Kuizon; C Yoon; B Gales; D Sider; Y Wang; J Chung; A Emerick; L Greaser; R M Elashoff; I B Salusky
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

4.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

5.  Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.

Authors:  B Peter Sawaya; Rezkalla Butros; Shehzab Naqvi; Zhaopo Geng; Hanna Mawad; Robert Friedler; Paolo Fanti; Marie-Claude Monier-Faugere; Hartmut H Malluche
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

6.  Aortic calcification and the risk of osteoporosis and fractures.

Authors:  Eloy Schulz; Kiumars Arfai; Xiaodong Liu; James Sayre; Vicente Gilsanz
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

7.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.

Authors:  J Braun; M Oldendorf; W Moshage; R Heidler; E Zeitler; F C Luft
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

8.  Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study.

Authors:  A Ishani; M Paudel; B C Taylor; E Barrett-Connor; S Jamal; M Canales; M Steffes; H A Fink; E Orwoll; S R Cummings; K E Ensrud
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

9.  Arterial calcifications and bone histomorphometry in end-stage renal disease.

Authors:  Gérard M London; Caroline Marty; Sylvain J Marchais; Alain P Guerin; Fabien Metivier; Marie-Christine de Vernejoul
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

10.  Renal osteodystrophy in CAPD patients.

Authors:  P Zucchelli; L Catizone; S Casanova; M Fusaroli; L Fabbri; G Ferrari
Journal:  Miner Electrolyte Metab       Date:  1984
View more
  40 in total

Review 1.  The bone-vascular axis in chronic kidney disease.

Authors:  Linda Demer; Yin Tintut
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-07       Impact factor: 2.894

2.  High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis.

Authors:  Hartmut H Malluche; Gustav Blomquist; Marie-Claude Monier-Faugere; Thomas L Cantor; Daniel L Davenport
Journal:  J Am Soc Nephrol       Date:  2015-04-02       Impact factor: 10.121

3.  Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat.

Authors:  John N Stabley; Rhonda D Prisby; Bradley J Behnke; Michael D Delp
Journal:  J Endocrinol       Date:  2015-04       Impact factor: 4.286

4.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

5.  Inflammation and the bone-vascular axis in end-stage renal disease.

Authors:  L Viaene; G J Behets; S Heye; K Claes; D Monbaliu; J Pirenne; P C D'Haese; P Evenepoel
Journal:  Osteoporos Int       Date:  2015-08-21       Impact factor: 4.507

6.  Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.

Authors:  Hartmut H Malluche; Hanna W Mawad; Marie-Claude Monier-Faugere
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

7.  Bone fracture risk factors in prevalent hemodialysis patients.

Authors:  Patrícia João Matias; Ivo Laranjinha; Ana Azevedo; Ana Raimundo; David Navarro; Cristina Jorge; Inês Aires; Marco Mendes; Carina Ferreira; Tiago Amaral; Célia Gil; Aníbal Ferreira
Journal:  J Bone Miner Metab       Date:  2019-09-05       Impact factor: 2.626

8.  Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Authors:  T-M Yu; C-L Lin; K-H Shu; Y-L Liu; C-H Chen; S-T Huang; C-H Kao
Journal:  Osteoporos Int       Date:  2014-12-10       Impact factor: 4.507

9.  Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Authors:  Andreas Pasch; Geoffrey A Block; Matthias Bachtler; Edward R Smith; Wilhelm Jahnen-Dechent; Spyridon Arampatzis; Glenn M Chertow; Patrick Parfrey; Xiaoye Ma; Juergen Floege
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

Review 10.  Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.

Authors:  Monica M Santisteban; Jasenka Zubcevic; David M Baekey; Mohan K Raizada
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.